Evidence map›Paper›PMID 11696237›Full record

ArticleBMC immunology2001

HIV infection and aging: enhanced Interferon- and Tumor Necrosis Factor-alpha production by the CD8+ CD28- T subset.

E H Eylar, C E Lefranc, Y Yamamura, I Báez, S L Colón-Martinez, N Rodriguez, T B Breithaupt

Open access · goldAbstract read
In one paragraph

Article in BMC immunology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Review
  8. Multiparameter Flow Cytometry Monitoring of T Cell Responses.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  9. Review
  10. Article
  11. Observational
  12. CD28Frontiers in medicine · 2020
    Article
  13. Review
  14. Increased frequencies of CD8Journal of the International AIDS Society · 2016
    Article
  15. Review
  16. Article
  17. CD8 T cell persistence in treated HIV infection.Current opinion in HIV and AIDS · 2014
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

E H EylarPonce School of Medicine, Biochemistry Department, PO Box 7004, Ponce, PR 00732-7004, USA. eheylar@yahoo.com
C E Lefranc
Y Yamamura
I Báez
S L Colón-Martinez
N Rodriguez
T B Breithaupt
Ponce Health Sciences University · PRDes Moines University · US

Funding

VIRAL SEQUENCES IN PEDIATRIC HIV INFECTION IN PRG12RR003050 · NCRR · PONCE SCHOOL OF MEDICINE · PI ARMSTRONG, RAUL A · 1985 to 2011
$28.1M
Therapeutic Immunization in Monkey Model of AIDSS06GM008239 · NIGMS · PONCE SCHOOL OF MEDICINE · PI MATTA, JAIME L · 1989 to 2009
$21.5M
NCRR NIH HHS 5 G 12RR03050NCRR NIH HHS G12 RR003050NIGMS NIH HHS S06 GM008239NIGMS NIH HHS S06 GM 08239
6 · The paper itself

Abstract

backgroundT cells from HIV+ and aged individuals show parallels in terms of suppressed proliferative activity and interleukin-2 (I1-2) production and an increased number of CD8+ CD28- T cells. In order to compare cytokine production from T cells from these two states, CD4+ and CD8+ T cells from HIV+ aged, and normal young donors (controls) were monitored for cytokine production by flow cytometry, quantitative PCR and ELISA upon activation by PMA and anti-CD3. In addition, the CD8+ T cell subsets CD28+ and CD28- from the HIV+ and the aged groups were evaluated for cytokine production by flow cytometry, and compared with those from young controls.

resultsFlow cytometric analysis indicated that CD8+ T cells from both HIV+ and aged donors showed an increase of approximately 2-3 fold over controls in percentage of cells producing inflammatory cytokines IFN-gamma and TNF-alpha. Similar analysis also revealed that the production of interleukins-4,6 and 10, production was very low (1-2% of cells) and unchanged in these cells. Quantitative PCR also showed a substantial increase (4-5 fold) in IFN-gamma and TNF-alpha mRNA from HIV+ and aged CD8+ T cells, as did ELISA for secreted IFN-gamma and TNF-alpha (2.3-4 fold). Flow cytometric analysis showed that the CD8+ CD28- T cell subset accounts for approximately 80-86% of the IFN-gamma and TNF-alpha production from the CD8+ subset in the aged and HIV+ states. The CD4+ T cell, while not significantly changed in the HIV+ or aged states in terms of IFN-gamma production, showed a small but significant increase in TNF-alpha production in both states.

conclusionsOur data appear compatible with physiologic conditions existing in HIV+ and aged individuals, i.e. elevated serum levels and elevated CD8+ T cell production of IFN-gamma and TNF-alpha. Thus, the capacity for increased production of cytokines IFN-gamma and TNF-alpha in the aged individual by the dominant CD8+ CD28- subset may have a profound influence on the clinical state by aggravating inflammatory pathologies such as rheumatoid arthritis, and possibly Alzheimer's disease and Crohn's disease. In AIDS, these cytokines may contribute to wasting and cachexia. We theorize that the predominant phenotypic change to the cytotoxic CD8+ CD28- T cell subsets in both the HIV+ and the aged states may reflect a natural "endpoint" in CD8+ T cell differentiation induced after a lifetime of immune activity (toward viruses, etc) in the aged, and after a massive accelerated response to HIV in the HIV-positive individual.

Indexed as

AgingAdultAgedCD28 AntigensCD8-Positive T-LymphocytesCytokinesEnzyme-Linked Immunosorbent AssayFlow CytometryHIV InfectionsHumansInterferonsRNA, MessengerT-LymphocytesTranscription, GeneticTumor Necrosis Factor-alphaCD28 AntigensCytokinesInterferonsRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID11696237
PMCPMC59583
OpenAlexW1514049966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.